Anavex Life Sciences Corp (AVXL)

[BAR123]

I think this is all BS. We don't need a larger study to be taken seriously. We need a partnership with big pharma for Alzheimers who will yell from the highest mountain that they have access to a monster drug with great results. Once that happens we are on the radar and we go to 30 - 50 rapidly. 1.2b mc. - 2B mc.

Then we begin P3 for Rhett, P3 for Parkinson, MS, etc. And we end the year at 60 - 80. 2.4 - 3.2 MC as word gets out that preliminary results are confirming what we already know. Then guess what. That is right, buyout at $125 or about a $6B market cap. That would be around this time next year.